Algernon’s decision will not affect any of its other research programs including investigating Ifenprodil for other disease indications. Algernon has several clinical stage programs currently in ...

--Algernon Pharmaceuticals Inc., a Canadian healthcare and clinical stage drug development company, is announcing amended pricing and warrant terms for its non-brokered private placement for gross ...

Algernon Pharmaceuticals stock (CSE:AGN) last traded at $0.09. While it has risen 28.57 per cent since the year began, it has lost 43.75 per cent since this time last year.

--Algernon Pharmaceuticals Inc., a Canadian clinical stage pharmaceutical development company, is pleased to announce that the United States Food and Drug Administration has granted Orphan Drug ...